Vicarious Surgical Receives NYSE Delisting Notice, Trading Suspended, Moving to OTCID
Summary
Vicarious Surgical Inc. has been notified by the NYSE of its immediate trading suspension and delisting due to failing to meet market capitalization requirements, with the company's stock expected to commence quotation on the OTCID market.
Key Events
-
NYSE Delisting Notice Received
On March 3, 2026, the company received notice from the NYSE that it had fallen below the continued listing standard requiring an average global market capitalization of at least $15,000,000 over a 30-trading day period.
-
Trading Immediately Suspended
The NYSE immediately suspended trading in the company's common stock and commenced proceedings to delist the shares.
-
Transition to OTCID Market
The company has received approval for its common stock to be quoted on the OTCID market tier, with quotation expected to begin on March 4, 2026, under the symbol 'RBOT'.
-
Potential Appeal Under Evaluation
Vicarious Surgical Inc. is currently evaluating whether to appeal the NYSE's delisting determination.
Analysis
The immediate suspension of trading and commencement of delisting proceedings by the NYSE is a critical negative event for Vicarious Surgical. This action, triggered by the company's failure to maintain an average global market capitalization of at least $15 million, significantly impairs the company's access to capital markets and reduces liquidity for shareholders. While the company is evaluating an appeal, the transition to the OTCID market tier is expected to result in a less liquid market and could further depress the stock price. This event fundamentally alters the company's public market status and investment thesis, signaling severe financial distress and challenges in future equity financing.
At the time of this filing, RBOT was trading at $1.98 on OTC in the Industrial Applications And Services sector. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.